The IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) announced that its expanded Code of Practice is now in effect around the world. The code governs “…how companies interact with healthcare professionals, medical institutions and patient organizations,” and has been adopted by all IFPMA member companies and member associations. Eduardo Pisani, IFPMA Director General, said, “Advancing medical knowledge and improving global public health depend on regular information-sharing interactions between the medical community and pharmaceutical companies. These exchanges ensure patients benefit from the most up-to-date information regarding medicines. Ensuring that governments, healthcare providers and patients are confident that interactions with our members are conducted to the highest ethical and professional standards is our commitment.”

More information about the IFPMA Code of Practice can be found at

http://www.ifpma.org/fileadmin/content/Publication/IFPMA_Code_of_Practice_2012.pdf

Full media release: http://www.ifpma.org/fileadmin/content/News/2012/FINAL_news_release_-_IFPMA_Code_of_Practice_-_1_Sept_2012.pdf